Janus Henderson Group PLC Sarepta Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,364,845 shares of SRPT stock, worth $64.7 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,364,845
Previous 4,328,323
22.26%
Holding current value
$64.7 Million
Previous $526 Million
59.2%
% of portfolio
0.12%
Previous 0.28%
Shares
28 transactions
Others Institutions Holding SRPT
# of Institutions
507Shares Held
89MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$199 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$174 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$174 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$78.2 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.67MShares$51.4 Million2.76% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.68B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...